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Background: There is evidence that several messenger RNAs (mRNAs) are bifunctional RNAs, i.e. RNA transcript
carrying both protein-coding capacity and activity as functional non-coding RNA via 5′ and 3′ untranslated
regions (UTRs).
Results: In this study, we identified a novel bifunctional RNA that is transcribed from insulin receptor substrate-1
(Irs-1) gene with full-length 5′UTR sequence (FL-Irs-1 mRNA). FL-Irs-1 mRNA was highly expressed only in skeletal
muscle tissue. In cultured skeletal muscle C2C12 cells, the FL-Irs-1 transcript functioned as a bifunctional mRNA. The
FL-Irs-1 transcript produced IRS-1 protein during differentiation of myoblasts into myotubes; however, this transcript
functioned as a regulatory RNA in proliferating myoblasts. The FL-Irs-1 5′UTR contains a partial complementary
sequence to Rb mRNA, which is a critical factor for myogenic differentiation. The overexpression of the 5′UTR markedly
reduced Rb mRNA expression, and this reduction was fully dependent on the complementary element and was not
compensated by IRS-1 protein. Conversely, knockdown of FL-Irs-1 mRNA increased Rb mRNA expression and enhanced
myoblast differentiation into myotubes.
Conclusions: Our findings suggest that the FL-Irs-1 transcript regulates myogenic differentiation as a regulatory RNA
in myoblasts.
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Recent genome-wide transcriptome studies discovered
that the mammalian genome is pervasively transcribed
into RNA. Within the protein-coding gene regions, there
are many alternative transcriptional start sites, which re-
sults in the production of not only protein-coding mRNA
but also non-protein-coding RNAs (ncRNAs) [1-6].
Intriguingly, the recent identification and characterization
of various mRNAs demonstrated that there are several bi-
functional mRNAs. The bifunctional RNA transcripts have
both protein-coding capacity and activity as functional
ncRNA in a context-dependent manner [7-9]. For example,* Correspondence: kondoshi@nutr.med.tokushima-u.ac.jp
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unless otherwise stated.steroid receptor activator RNA (SRA) acts as bifunctional
transcript. Non-coding SRA stimulates transcriptional ac-
tivity of MyoD and enhances muscle cell differentiation,
whereas SRA protein binds to and counteracts SRA ncRNA
function [10-13]. p53 mRNA interacts with MDM2 protein
and prevents MDM2 function [14]. The untranslated re-
gion (UTR) of several mRNA transcripts can also function
as a trans-acting regulatory RNA that is independent of the
protein-coding functions. Several mRNA 3′UTRs act as
competing endogenous RNAs (ceRNAs) or natural micro-
RNA sponges. Examples include the 3′UTR of PTEN
mRNA [15], the 3′UTR of ZEB2 mRNA [16] and the 3′
UTR of Hmga2 mRNA [17]. The 5′UTR of mRNA also
acts as regulatory RNA, as we have previously reported that
the 5′UTR of VEGF mRNA promotes tumor malignancy
by silencing of STAT1 mRNA expression [18].l. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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investigating functional RNAs, because it can be recapit-
ulated in vitro and because the myogenic differentiation
program is well characterized and evolutionarily con-
served [19]. There is increasing evidence to support that
several ncRNAs, such as linc-MD1, SINE-containing
ncRNAs, and the 3′UTR of DMPK (dystrophia myoto-
nica protein kinase) mRNA regulate myogenesis through
modulation of myogenic gene expression, such as Pax3,
MyoD, Myf5, and miRNA-133 and −135 [20-23].
Skeletal muscle differentiation occurs by a stepwise
progression. The expression of the retinoblastoma pro-
tein (Rb) is critically important to this process [24-30].
The role of Rb is multifaceted and includes the orchestra-
tion of cell cycle arrest and prevention of cell cycle reen-
try. Furthermore, Rb also enforces a stable muscle-specific
gene expression. Thus, the silencing of Rb expression by
siRNA or gene knockout abrogates myoblast differenti-
ation [25,28].
In this study, we focused on insulin receptor
substrate-1 (Irs-1) gene products because IRS-1 plays
critical roles in myogenic growth and differentiation as
previously demonstrated by our group and others
[31,32]. We found that one of the transcriptional vari-
ants of Irs-1 mRNA was highly expressed in skeletal
muscle relative to liver and adipose tissue. We demon-
strate that the Irs-1 transcript is a bifunctional mRNA.
The 5′UTR of the Irs-1 transcript repressed Rb mRNA
expression and suppressed muscle cell differentiation.
Our results suggest that the Irs-1 transcript is a regulator
of myogenic differentiation.
Results
Characterization of mouse Irs-1 transcriptional variants
Mouse Irs-1 gene consists of two exons and one intron.
The exon 1 encodes 5′UTR, IRS-1 protein sequence and
partial 3'UTR, while the exon 2 encodes only 3′UTR
(Figure 1A). A bioinformatics analysis of the mouse Irs-1
gene region using the UCSC genome database [33] revealed
11 different transcriptional variants in the Irs-1 gene region,
including IRS-1 protein-coding mRNAs and non-protein
coding transcripts. Each of the transcripts is derived from a
distinct transcription start site and has a transcriptional
termination site. The database includes tissue- and cell type-
specific expression of Irs-1-related transcripts (Additional
file 1: Figure S1A). For instance, heart and liver express Irs-1
mRNA (GenBank accession number AK045317), while
brain poorly expresses it. Fibrocytes and fibroblasts express
several Irs-1 transcripts, whereas MEL cells, erythroblasts
and megakaryocytes do not express any Irs-1 transcripts.
Notably, exon 2-derived transcripts (BC034138, AK052241,
AK136875, AK141842 and AK169784) that do not encode
IRS-1 protein are highly expressed in several tissues
(cerebellum, brain, heart and liver) and cells (fibrocytesand fibroblasts). Fibroblasts clearly express intron 1-
derived non-coding transcript (AK137314) (Additional
file 1: Figure S1A).
We tried to measure the expression profile of these
unique transcripts in several mouse tissues and C2C12
muscle cell lines by quantitative RT-PCR (qRT-PCR)
using specific primer sets for each transcript (indicated
in Additional file 1: Figure S1A). The intron 1-derived tran-
script (AK137314) was ubiquitously expressed (Additional
file 1: Figure S1B). However, we could not determine the
levels of exon 2-derived transcripts (BC034138, AK052241,
AK136875 and AK141842), since they were not amplified
by qPCR using our primer set.
Characterization of two distinct Irs-1 mRNAs expression
We are interested in whether the 5′UTR of mRNA acts as
functional RNA similar to results we previously demon-
strated [18]. Therefore, we focused on two Irs-1mRNA var-
iants that have different 5′UTRs because of different
transcription start sites (Figure 1A). As shown in Figure 1A,
one is transcribed from a + 1 nucleotide (nt) transcription
start site in exon 1, thus it contains full-length 5′UTR se-
quence (FL-Irs-1 mRNA). The other variant is transcribed
from a + 534 nt transcription start site in exon 1 and results
in a short 5′UTR sequence (s5′-Irs-1 mRNA). Both FL- and
s5′-Irs-1mRNAs contain the same protein coding sequence
(CDS) encoding exon 1 and should produce the same IRS-
1 protein (Figure 1A).
We then examined the expression profile of the two
Irs-1 transcripts in several mouse tissues by qRT-PCR
using a specific primer set for each transcript (indicated in
Figure 1A). s5′-Irs-1 mRNA was ubiquitously expressed in
multiple tissues, especially in adipose tissue, liver and skel-
etal muscle that are well known tissues highly expressing
IRS-1 protein [34-36] (Figure 1B). Interestingly, FL-Irs-1
mRNA was highly expressed only in skeletal muscle
(Figure 1C), which suggests that FL-Irs-1 mRNA may have
a skeletal muscle-specific function.
To determine the expression profile of the two Irs-1
mRNA transcripts during myogenesis, we used mouse
myoblast cell line C2C12 that is a well characterized model
system for studying muscle differentiation in vitro. C2C12
cells proliferate as myoblasts in growth medium (GM),
while confluent C2C12 myoblasts exit the cell cycle and
fuse with one another to form multinucleated muscle cells
(myotubes) in differentiation medium (DM). The expres-
sion levels of s5′-Irs-1 mRNA were low in myoblasts and
increased by 3.6-fold in myotubes (Figure 1B). In contrast,
FL- Irs-1 mRNA levels were relatively high in myoblasts,
but decreased in differentiated myotubes (Figure 1C).
When comparing the levels of s5′- and FL-Irs-1 mRNAs
between skeletal muscle tissue and C2C12 myotubes,
expression levels of both mRNAs were similar
(Figure 1B,C). In C2C12 myoblasts, s5′-Irs-1 mRNA
Figure 1 Characterization of two distinct Irs-1 transcripts. (A) Schematic representation of two transcriptional variants of mouse Irs-1 mRNAs
(FL-Irs-1 and s5′-Irs-1 mRNAs). The positions of specific qPCR primer sets are shown as arrows (red is for FL-Irs-1, blue is for s5′-Irs-1mRNA). (B) Expression
levels of s5′-Irs-1mRNA in the indicated mouse tissues, proliferating C2C12 myoblasts (GM, growth medium) and differentiating C2C12 myotubes (DM4,
differentiation medium for 4 days). Mean ± SD, n = 4-6. (C) Expression levels of FL-Irs-1mRNA in the indicated mouse tissues, C2C12 myoblasts (GM) and
C2C12 myotubes (DM4). Mean ± SD, n = 4-6. (D,E) Specific knockdown of FL-Irs-1 mRNA (d) or s5′-Irs-1 mRNA (e) in myoblasts (GM) and myotubes (DM4).
Mean ± SD, n = 4, *p < 0.01 versus no treatment (none). (F) Effect of specific knockdown of FL-Irs-1 mRNA or s5′ Irs-1mRNA on IRS-1 protein expression
during myogenesis. (G) Quantification analysis and statistic were performed on three independent experiments. Mean ± SD, *p < 0.01 versus each culture
conditions (GM, DM1 or DM3) in no transfection (none). n.s., not significant.
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Irs-1 mRNA levels were higher (Figure 1B,C).
To determine an expression relationship between the
two Irs-1 mRNAs and IRS-1 protein in C2C12 cell myo-
genic process, FL-Irs-1 mRNA or s5′-Irs-1 mRNA wasspecifically knocked down by targeting their 3′UTR se-
quence encoded in exon 2 (FL-Irs-1 mRNA) or in intron
1 (s5′-Irs-1 mRNA) (Figure 1A). The si-s5′-Irs-1 reduced
s5′-Irs-1 mRNA levels to approximately 30% of control
cells without affecting FL-Irs-1 mRNA levels (Figure 1D).
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Figure 2 FL-Irs-1 transcript regulates C2C12 differentiation.
(A,B) Effect of knockdown of FL-Irs-1 mRNA on differentiation of
C2C12 myoblast. Fusion index (A) and a mean diameter of myotubes
(B) are shown. Mean ± SD, n = 50, *p < 0.01 versus no treatment (none).
(C) Effect of knockdown of FL- Irs-1 mRNA on expression levels of
myosin heavy chain in differentiating C2C12 cells (DM2, 4 and 6).
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levels to approximately 20% compared with the sh-control
and did not alter s5′-Irs-1 mRNA levels (Figure 1E).
In untransfected (none) or control transfected cells
(sh-control), the IRS-1 protein levels were increased dur-
ing differentiation from myoblasts to myotubes (Figure 1
F,G). When FL-Irs-1 mRNA was knocked down, the
IRS-1 protein levels decreased in differentiating myotubes
but not in proliferating myoblasts (Figure 1 F,G). In con-
trast, knockdown of s5′-Irs-1 mRNA clearly reduced
IRS-1 protein levels in both myoblasts and myotubes
(Figure 1 F,G). These results indicate that the s5′-Irs-1 tran-
script participates in continuous IRS-1 protein production
during myogenesis and that FL-Irs-1 mRNA is involved in
IRS-1 protein synthesis only in differentiating myotubes.
FL-Irs-1 transcript regulates myoblast differentiation
In myoblasts, the FL-Irs-1 transcript was highly expressed
and was not involved in IRS-1 protein production. There-
fore, we hypothesized that FL-Irs-1 mRNA functions as an
ncRNA with activity independent of its protein-coding
function. To address this hypothesis, we examined the ef-
fect of knockdown of FL-Irs-1 transcript on the C2C12
cell phenotype. The knockdown of FL- Irs-1 mRNA mark-
edly enhanced differentiation into myotubes (Figure 2).
The results of fusion index show that the number of dif-
ferentiated myotubes was increased more than 3-fold by
knockdown of FL- Irs-1 mRNA compared with untrans-
fected and sh-control-transfected cells (Figure 2A). The
mean diameter of myotubes was also increased by ap-
proximately 130% after knockdown of FL-Irs-1 mRNA
(Figure 2B). The expression of myosin heavy chain, which
is a myogenic differentiation marker, was also enhanced
by knockdown of FL-Irs-1 mRNA (Figure 2C). In contrast,
knockdown of s5′-Irs-1 mRNA did not affect C2C12 cell
differentiation (Additional file 2: Figure S2). These data in-
dicate that accelerated differentiation by knockdown of
FL-Irs-1 transcript was not caused by a reduction of IRS-1
protein, but instead, by a blockade of FL-Irs-1 transcript
function.
It is well known that Rb plays a critical role in indu-
cing myogenic differentiation, and the introduction of
Rb in myoblasts accelerates differentiation to myotubes
[24-26]. Conversely, inhibition of Rb expression in myo-
blasts abrogates differentiation into myotubes [27,28].
Thus, we hypothesized that FL-Irs-1 transcript may
affect Rb expression.
FL-Irs-1 5′UTR reduces Rb mRNA expression in
C2C12 cells
We examined the expression levels of Rb mRNA in
myoblasts and myotubes. Myoblasts expressed low
levels of Rb mRNA and myotubes expressed higher
levels (Figure 3A). The Rb mRNA expression profilehad an inverse relationship with FL-Irs-1 transcript
levels (Figure 1C, C2C12 cells).
A bioinformatics analysis showed that there was a par-
tial sequence-complementary element between the 5′
UTR of FL-Irs-1 transcript and Rb mRNA (Figure 3B,C).
Given that several functional RNA transcripts can inter-
act with target mRNAs by intermolecular base-pairing
via a partially complementary element [21,22,37], FL-Irs-
1 5′UTR may target Rb mRNA via the complementary
element. To assess whether FL- Irs-1 5′UTR participated
in Rb expression, C2C12 myoblasts were transfected
with an Rb mRNA-expressing plasmid in combination
with a plasmid expressing the FL-Irs-1 5′UTR fused to
the luciferase gene (pFL-5′UTR-Luc) or a control
Figure 3 (See legend on next page.)
Nagano et al. BMC Cell Biology  (2015) 16:8 Page 5 of 10
(See figure on previous page.)
Figure 3 FL-Irs-1 transcript reduces Rb mRNA levels. (A) Expression levels of Rb mRNA in C2C12 myoblasts (GM) and myotubes (DM4).
(B) Partial sequence complementarity between the 5′UTR of FL-Irs-1 transcript (nt 373 – nt 405) and Rb mRNA (nt 131 – nt 165). (C) Schematic
representation of position of complementary element in the 5′UTR of FL-Irs-1 transcript. A position of an LNA-based antisense oligonucleotide
(FL-5′-AS-ODN) is shown. (D) Effect of FL-Irs-1 5′UTR on Rb mRNA expression levels. C2C12 myoblasts were untransfected (−) or transfected with
an Rb mRNA-expressing plasmid in combination with the indicated effector plasmid (pFL-5′UTR, pFL-5′UTR-del). Rb mRNA levels were measured
by qRT-PCR. Mean ± SD, n = 4-5, *p < 0.01 versus control transfectant (pRB + pLuc). (E) Effect of FL-5′-AS-ODN on Rb mRNA reduction by FL-Irs-1
5′UTR. C2C12 myoblasts were co-transfected with plasmids expressing Rb mRNA and the FL-Irs-1 5′UTR RNA in combination with the indicated
AS-ODN. Mean ± SD, n = 4-5, *p < 0.01 versus control transfectant (pRB + pLuc). (F) Effect of knockdown of endogenous FL-Irs-1 transcript on
endogenous Rb mRNA levels. C2C12 myoblasts were transfected with the indicated shRNA or siRNA. Mean ± SD, n = 4, *p < 0.01 versus no
treatment (none). (G) Effect of supplementary expression of IRS-1 protein on Rb mRNA levels under FL-Irs-1 transcript knockdown conditions.
C2C12 myoblasts were transfected with the sh-FL-Irs-1 plasmid in combination with a plasmid encoding IRS-1 protein fused to V5 tag (pIRS-1-V5).
Expression levels of exogenous IRS-1 protein were determined by immunoblot analysis using anti-V5 antibody. Mean ± SD, n = 3, *p < 0.01 versus
control transfectant (sh-Control).
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but not control plasmid, markedly reduced Rb mRNA
levels (Figure 3D). To demonstrate that the complementary
element in the 5′UTR was responsible for the reduction of
Rb mRNA, we deleted the complementary element (pFL-5′
UTR-del). The deletion of the element fully abrogated the
ability to decrease Rb mRNA expression (Figure 3D).
To exclude the possibility that the deletion may affect the
secondary structure of FL-Irs-1 5′UTR, resulting in a loss
of silencing activity for Rb mRNA, we examined effect of
an LNA-based antisense oligonucleotide against the com-
plementary element (FL-5′-AS-ODN). FL-5′-AS-ODN, but
not control AS-ODN, completely prevented the decrease of
Rb mRNA expression induced by FL-Irs-1 5′UTR
(Figure 3E). These results indicated that FL-Irs-1 5′UTR de-
creased Rb mRNA levels via its complementary sequence.
To verify that endogenous FL-Irs-1 transcript partici-
pated in endogenous Rb mRNA expression, we knocked
down the FL-Irs-1 transcript. The silencing of FL-Irs-1
mRNA increased Rb mRNA levels by more than 2-fold
(Figure 3 F). In contrast, knockdown of s5′-Irs-1 mRNA
did not affect the Rb mRNA levels. These results suggest
that the elevation of Rb mRNA levels was not caused by
decreasing IRS-1 protein after knockdown of FL-Irs-1
transcript. The supplementary expression of exogenous
IRS-1 protein using an IRS-1-expressing plasmid that
encodes only the open reading frame of IRS-1 without
the 5′ and 3′-UTRs did not affect the elevation of Rb
mRNA levels (Figure 3G).
We additionally examined the effect of knockdown of
FL-Irs-1 transcript on other myogenic regulators
expression, such as MyoD, myogenin, Myf5, MRF4 and
MEF2. The silencing of FL-Irs-1 mRNA did not affect
the levels of all myogenic factors tested (Additional
file 3: Figure S3).
FL-Irs-1 5′UTR does not reduce Rb mRNA expression
in hepatocytes
We further tested whether the FL-Irs-1 5′UTR-induced
Rb mRNA reduction occurred in hepatocytes becauseIRS-1 is an important factor in hepatocytes. A cultured
hepatocyte cell line was co-transfected with plasmids ex-
pressing Rb mRNA and the FL-Irs-1 5′UTR. Unlike skel-
etal muscle cells, the overexpression of the 5′UTR did
not reduce Rb mRNA levels in hepatocytes (Figure 4A).
In addition, knockdown of FL-Irs-1 transcript did not
alter Rb mRNA levels in hepatocytes (Figure 4B,C).
Reduction of Rb mRNA by FL-Irs-1 transcript did not
require Dicer and Upf1
We then examined the molecular mechanism respon-
sible for FL-Irs-1 5′UTR reducing Rb mRNA levels.
There is evidence that several miRNAs and ncRNAs
regulate myogenic differentiation through the Dicer- and
Upf1-mediated target mRNA decay system [21,22]. The
knockdown of Dicer or Upf1 by siRNA (Additional file
4: Figure S4A, B) did not alter the suppression of Rb
mRNA by FL-Irs-1 5′UTR (Additional file 4: Figure
S4C). In addition, northern blot analysis using FL-5′-AS-
ODN showed a small RNA with approximately 20–25 nt
in length or the 5′UTR RNA distinct from FL-Irs-1
mRNA was not detected in either myoblasts and myo-
tubes (Additional file 4: Figure S4D). These data suggest
that FL-Irs-1 transcript was not processed to miRNA or
intermediate 5′UTR RNA.
Discussion
In this study, we found that FL-Irs-1 transcript acts as a
bifunctional RNA. One function is as a regulatory RNA
in proliferating myoblasts that reduced Rb mRNA ex-
pression and suppressed myoblast differentiation. The
other function is as mRNA that produced IRS-1 protein
during differentiation into myotubes. By contrast, s5′-Irs-1
mRNA was only involved in IRS-1 protein synthesis dur-
ing myogenesis.
Rb plays a crucial role in the switch from proliferation
to differentiation in myoblasts [24-28]. Myoblasts lack-
ing Rb lose the capacity to differentiate into myotubes
[27,28], and the overexpression of Rb in myoblasts en-
hances differentiation into myotubes [25]. It is well
Figure 4 FL-Irs-1 transcript does not reduce Rb mRNA
expression in hepatocytes. (A) Effect of FL-Irs-1 5′UTR on Rb mRNA
expression levels. Cultured hepatocyte cell lines (NCTC clone 1469)
were untransfected (−) or transfected with an Rb mRNA-expressing
plasmid in combination with the indicated effector plasmid. Rb mRNA
levels were measured by qRT-PCR. Mean ± SD, n = 4, *p < 0.01 versus
control transfectant (pRB + pLuc). (B,C) Effect of knockdown of
endogenous FL-Irs-1 transcript on endogenous Rb mRNA levels.
Cultured hepatocyte cell lines were transfected with the indicated
shRNA. FL-Irs-1 (B) and Rb mRNA (C) levels were measured by
qRT-PCR. Mean ± SD, n = 4, *p < 0.01 versus no treatment (none).
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tional modification (phosphorylation levels) during myo-
blast differentiation. Although it is considered that the
Rb expression levels are tightly regulated in myoblasts
before and during differentiation, how Rb levels are regu-
lated in myoblasts is still unclear. In this study, the knock-
down of endogenous FL-Irs-1 transcript increased Rb
mRNA levels and accelerated differentiation of myoblasts
to myotubes. Thus, our findings suggest that FL-Irs-1
transcript could be one of the endogenous downregulator
(s) of Rb expression in myoblasts.
A functional relevance of between IRS-1 protein and Rb
protein was previously reported [38-40]. IRS-1 inhibits
transcriptional activity of Rb [38]. In addition, several re-
ports indicate that the IGF-1/IRS-1 pathway suppresses
Rb-mediated cell cycle arrest by inducing prolongedphosphorylation of Rb [39,40]. However, at least to our
best knowledge, our study is the first report showing a re-
lationship between Irs-1 transcript and Rb mRNA.
There are several ncRNAs that regulate myogenesis
through modulation of myogenic gene expression, such
as Pax3 [21], Myf5 [22], MyoD [23], and miRNA-133
and −135 [20]. Several SINE-containing ncRNAs and
mRNAs interact with their target mRNAs such as Myf5
by base-pairing with partially complementary elements
to induce degradation of them and regulate C2C12 cell
myogenesis [21,22]. In these cases, the silencing of target
mRNAs by the ncRNAs requires base-pairing to target
mRNA and a Dicer- and Upf1-dependent mechanism
[21,22]. Here, we demonstrated that the reduction of Rb
mRNA by FL-Irs-1 transcript did not require Dicer and
Upf1. However, the complementary element in the 5′UTR
of FL-Irs-1 transcript was necessary to decrease Rb mRNA
levels. In addition, the reduction of Rb mRNA by the FL-
Irs-1 transcript was not observed in hepatocytes despite
the important role of Rb in hepatocyte differentiation
[41]. Thus, skeletal muscle-specific factors may be re-
quired in Rb mRNA silencing. Further studies are re-
quired to clarify a molecular mechanism of FL-Irs-1
transcript-mediated gene silencing.
Until recently, it has been generally accepted that
mRNA functions only in protein production, and cell phe-
notypes depend exclusively on the function of these pro-
teins. Unexpectedly, recent studies demonstrated that
several mRNAs may have bifunctional abilities in a
context-dependent manner. It is predicted that the human
genome contains approximately 300 possible potentially
new bifunctional mRNAs [8]. One characterized bifunc-
tional mRNA is SRA during myogenic processes [10-13].
In myogenic proliferation, the protein-coding SRA tran-
script is abundantly expressed, and SRA protein binds to
and counteracts SRA ncRNA-mediated MyoD activation
and suppresses differentiation [10]. During myogenic dif-
ferentiation, the expression of non-coding SRA transcript
is elevated and enhances transcriptional activity of MyoD
and differentiation [11-13]. These findings suggest that the
effect of SRA on myogenesis may result from the correct
balance between non-coding and coding SRA transcripts.
The present study showed that the balance between cod-
ing and non-coding Irs-1 transcripts may be important for
regulating myogenic differentiation.
Beyond UTRs function as cis regulatory elements that
impact the translational activity and stability of their
own mRNAs, UTRs are also trans modulator of gene ex-
pression through their target transcript inhibition as dem-
onstrated here and by others [15-17]. As recently
suggested by the Pandolfi group [42-45], mRNA tran-
scripts can potentially perturb the interaction with target
RNAs and possess a biological activity independent of the
translation of the protein they encode. Therefore, some of
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the protein function but also on the regulatory RNA func-
tion that is distinct from their protein products.
Conclusions
The objective of this study was to identify a novel bi-
functional RNA in myogenic process. We found that FL-
Irs-1 transcript regulates Rb expression at the RNA
levels independent of its protein-coding function. Our
findings suggest that FL-Irs-1 transcript functions as a
bifunctional RNA during myogenic differentiation.
Methods
Cell culture
C2C12 myoblast cells were cultured in Dulbecco’s Modi-
fied Eagle Medium (DMEM) containing 10% fetal bovine
serum (FBS) and penicillin-streptomycin mixed solution
(Nacalai Tesque, Kyoto, JAPAN) at 37°C with 5% CO2.
When confluent, myogenic differentiation was induced by
changing media to DMEM supplemented with 2% horse
serum and penicillin-streptomycin mixed solution at 37°C
with 5% CO2. Mouse hepatocyte cell lines (NCTC clone
1469) were cultured in NCTC 135 medium containing
10% horse serum and penicillin-streptomycin mixed solu-
tion at 37°C with 5% CO2.
siRNA and transfection
Stelth RNAi negative control siRNA (medium GC con-
tent, Invitrogen) or Silencer Select negative control #1
siRNA (Ambion) was used as a control siRNA, which has
no homology to human gene products. The siRNA target-
ing mouse Dicer mRNA duplex targets 5′-GCCGAUCUC
UAAUUACGUA TT-3′ (Ambion). The siRNA targeting
mouse Upf1 mRNA targets 5′-CAGUUACUGUGGAA
UCCAUTT-3′ (Ambion). The siRNAs targeting s5′-Irs1
mRNA targets 5′-UCGCCAAACUUAACGUUCUAUCA
AA-3′ (Invitrogen). Cells were transfected with siRNA
using jetPRIME™ DNA reagent (Polyplus-transfection,
Illkirch, France), according to the manufacturer’s instruc-
tions. Transfection efficiency of siRNA was approximately
60-70% that was determined using BLOCK-iT Alexa Fluor
Red Fluorescent Oligo (Invitrogen).
Plasmid construction and transfection
A plasmid encoding mouse Rb sequence was purchased
from Kazusa DNA Res. Inst. A plasmid expressing IRS-1
protein was constructed as described previously [31].
FL-Irs-1 5′UTR and FL-Irs-1 5′UTR-del sequences were
synthesized by custom gene synthesis technology (Gen-
Script Inc). The synthesized double strand DNA was
cloned into the phCMV-FSR luciferase vector (pLuc, Gen-
lantis). Insert sequence was verified by DNA sequencing.
A plasmid expressing shRNA targeted against FL-Irs1
mRNA exon 2(5′- GGAGAGAGTATTAAATATT -3′)was constructed using the piGENE-U6-Rep vector (iGene
Therapeutics Inc., Tsukuba, Japan). The piGENE-U6-Rep
vector containing seven tandem repeats of thymidine (T7)
served as the negative control vector. The shRNAs were
transfected into cells by jetPRIME™ DNA reagent accord-
ing to manufacturer’s instructions. Transfected cells were
selected with 4 ug/ml puromycin 24 hours after transfec-
tion and changed to fresh selection medium for additional
10 days.Quantitative RT-PCR (qRT-PCR)
SuperScript II RNase H-reverse transcriptase (Invitrogen)
was used to synthesize cDNAs from 500 ng aliquots of
total RNA. The levels of s5′-Irs1 mRNA, FL-Irs1 mRNA,
Rb mRNA and 18S ribosomal RNA were measured by real
time (RT)-PCR using the following specific primer sets:
s5′-Irs1, 5′- TATGCCAGCATCAGCTTCC -3′ (forward)
and 5′- TAAAAACGCACCTGCTGTGA -3′ (reverse);
FL-Irs1, 5′- CTATGCCAGCATCAGCTTCC -3′ (forward)
and 5′- TTGCTGAGGTCATTTAGGTCTTC −3′ (reverse);
Rb, 5′- AATTAGAACGGACGTGTGAACTT -3′ (forward)
and 5′- CCAAGAAATTTTTAGCACCAACA -3′ (reverse);
18S rRNA, 5′- GCAATTATTCCCCATGAACG -3′ (for-
ward) and 5′- GGGACTTAATCAACGCAAGC -3′ (re-
verse). Amplification and quantification of the PCR
products were performed using the Applied Biosystems
7500 System (Applied Biosystems). Standards were run
in the same plate and the relative standard curve
method was used to calculate the relative mRNA ex-
pression. RNA amounts were normalized against the18S
ribosomal RNA level.
Western and Northern blot analyses
Cell lysates were prepared using a lysis buffer containing
100 mM Tris–HCl (pH 6.8), 300 mM NaCl, 2 mM EDTA
and 4% (v/v) SDS. Western immunoblotting was per-
formed as described previously [18,31] using rabbit poly-
clonal anti-IRS-1 (Calbiochem, La Jolla, CA), mouse
monoclonal anti-MHC (myosin heavy chain, fast) (Sigma),
rabbit polyclonal anti-α-tubulin (Santa Cruz Biotechnol-
ogy, USA), or rabbit polyclonal anti-GAPDH (Santa Cruz
Biotechnology, USA). Densitometric analysis was per-
formed using the ImagePro software as described previ-
ously [18].
Total RNA was prepared by the guanidinium thio-
cyanate method using ISOGEN reagent (Wako,
Japan). Northern hybridization was performed as de-
scribed previously [18] using LNA-based antisense
oligonucleotide probe for the complementary se-
quence in the FL- Irs1 mRNA 5′UTR (Figure 3B).
The hybridized blots were exposed to BAS1500 Im-
aging screen (FujiFilm) for 1 h, then the images were
developed.
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Nuclei of C2C12 myotubes were fixed and stained using
propidium iodide. Each well was photographed in six ran-
domly selected regions at × 20 magnifications at day 3 or
day 5 post-differentiation induction using a BIOREVO
BZ-9000 fluorescent microscope (Keyence, Osaka, Japan).
The number of nuclei incorporated in myotubes and the
total number of nuclei were scored. Fusion index was cal-
culated as the percentage of total nuclei incorporated in
myotubes. Diameter of myotubes was measured using
BIOREVO BZ-9000 software (Keyence).
Statistical analysis
Results are expressed as means ± S.D. Statistical analyses
of data were done using ANOVA and the Scheffé’s test.
P values < 0.05 was considered significant.
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Additional file 1: Figure S1. Abundance and tissue/cell type
distribution of Irs-1 transcript variants.
Additional file 2: Figure S2. Effect of s5′-Irs-1 transcript on
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Additional file 3: Figure S3. Effect of FL-Irs-1 transcript on expression
of several myogenic factors.
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FL-Irs-1 function.
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